Arcus Biosciences, Inc.RCUSNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 5Y Ago
-4.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-482.00M-183.5%
2024$-170.00M+44.4%
2023$-306.00M-169.9%
2022$438.00M+271.0%
2021$-256.17M-330.4%
2020$111.17M+251.3%
2019$-73.46M-70.9%
2018$-43.00M-71.6%
2017$-25.06M-93.6%
2016$-12.94M-